Abstract: A fabrication and monitoring device for micro probe ball tips includes a magnetic field generator, a 3-dimensional displacement adjusting mechanism, a wire supplier and an image monitoring system. The magnetic field generator includes a U-shaped electromagnet. The 3-dimensional displacement adjusting mechanism includes a 2-dimensional moving platform, a 1-dimensional moving platform, a guiding tube, and a sparking plug. The wire supplier includes a transmission wheel, a pressing roller, a wire feeding roller and a tungsten wire material supplier. The image monitoring system includes a micro objective, a third-generation infinite beam structure lens and a supporting frame. The present invention overcomes an eccentric problem of a tungsten ball and a tungsten rod, and also overcomes a sphericity problem caused by gravity, so as to improve sphericity, eccentric accuracy and enable monitoring of dynamic manufacturing process of the probe ball tips.

Abstract: A single sensor type three-dimensional micro/nano contact trigger measuring probe is provided which is characterized in respectively providing a probe unit and a measuring unit in the base. In the probe unit, the leaf spring is supported on the circular-ring base, a circular suspension plate is provided on the leaf spring, and beam splitter prisms and wedge block are fixedly provided on the circular suspension plate. The stylus and the circular suspension plate are fixedly connected in a ‘T” shape. The measuring unit projects the straight light emitted by a laser device through the beam splitter prisms and wedge block and then the straight light is focused on the four-quadrant detector. Measuring the offset of the probe by the four-quadrant detector, in such a manner that single sensor type three-dimensional micrometer contact trigger measurement is achieved.

Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: A compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, is provided. Also, a composition containing a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents, is provided. Further, use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof for anti-apoptosis is provided, preventing or treating a disease or disorder associated with apoptosis; especially for protecting cardiomyocyte, preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.

Abstract: A new Verbena plant particularly distinguished by large pink and white flowers having good color contrast, good branching and an early flowering time, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large, pink flowers with white centers, an upright plant habit, good tolerance to powdery mildew, and early flowering, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large, red-purple flowers with white centers, a semi-upright plant habit, good tolerance to powdery mildew, and early flowering, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large pink, purple and white flowers, a semi-trailing growth habit, a high number of branches and medium vigor, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large pink and white flowers having good color contrast, good branching and an early flowering time, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large, red-purple flowers with white centers, a semi-upright plant habit, good tolerance to powdery mildew, and early flowering, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large, pink flowers with white centers, an upright plant habit, good tolerance to powdery mildew, and early flowering, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large purple and white flowers, excellent flower richness, early flowering time, a strong growth habit and good resistance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by a red flower color with small white eyes, large flower size and good resistance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by dark blue-violet flowers with white eyes, early flowering, and good resistance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by large, white flowers, early to flower, and good tolerance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by pink flowers with darker pink eyes, good branching and an upright plant habit, and good tolerance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by orange-red flowers with darker eyes, an upright plant habit, and good tolerance to powdery mildew, is disclosed.

Abstract: A new Verbena plant particularly distinguished by violet-blue flowers, a semi-upright plant habit, and good tolerance to powdery mildew, is disclosed.